News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Conference News EACTS 2023 Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry Michael O'Riordan October 11, 2023
News Conference News EACTS 2023 AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair Michael O'Riordan October 09, 2023
News Conference News EACTS 2023 SWEDEHEART Hints at Mortality Benefit With Statins After SAVR Michael O'Riordan October 05, 2023
News Daily News Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted? Michael O'Riordan September 21, 2023
News Daily News Abbott to Stop Making Trifecta Surgical Aortic Valves Michael O'Riordan July 31, 2023
News Conference News TVT 2023 Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes Michael O'Riordan June 13, 2023
News Conference News EuroPCR 2023 Up and Away: TAVI Early Discharge Protocols Safely Cut Length of Stay Michael O'Riordan May 18, 2023
News Conference News EuroPCR 2023 Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics Michael O'Riordan May 17, 2023
News Conference News EuroPCR 2023 BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction Michael O'Riordan May 16, 2023
News Conference News AATS 2023 Beware High-Risk TAVI in Patients With Low-Lying Coronaries Michael O'Riordan May 11, 2023
News Daily News TAVI Explantation Remains a Risky Proposition, Two New Studies Show Michael O'Riordan April 27, 2023
News Conference News EHRA 2023 EPs Push for More Involvement in TAVI Heart Team Discussions Michael O'Riordan April 21, 2023
News Daily News Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data Michael O'Riordan March 29, 2023
News Daily News For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI Michael O'Riordan February 23, 2023
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023